$MNTA patent settlement with $ABBV allows US #biosimilar #Humira launch Nov. 20, 2023; BLA submission planned for Q4 https://t.co/aLWLZdiKuZ
$MNTA patent settlement with $ABBV allows US #biosimilar #Humira launch Nov. 20, 2023; BLA submission planned for Q4 https://t.co/aLWLZdiKuZ